Pharmacokinetic Effects of Coadministration of Lersivirine with Raltegravir or Maraviroc in Healthy Subjects

Lignende værker

• Lack of a Clinically Relevant Effect of an Antacid on the Pharmacokinetics of Lersivirine
  af: Vourvahis, M., et al.
  Udgivet: (2010)
• Effects of ketoconazole and valproic acid on the pharmacokinetics of the next generation NNRTI, lersivirine (UK-453,061), in healthy adult subjects
  af: Langdon, Grant, et al.
  Udgivet: (2012)
• Effect of Rifampin and Rifabutin on the Pharmacokinetics of Lersivirine and Effect of Lersivirine on the Pharmacokinetics of Rifabutin and 25-O-Desacetyl-Rifabutin in Healthy Subjects
  af: Vourvahis, Manoli, et al.
  Udgivet: (2012)
• Pharmacokinetic Interaction between Maraviroc and Fosamprenavir-Ritonavir: an Open-Label, Fixed-Sequence Study in Healthy Subjects
  af: Vourvahis, Manoli, et al.
  Udgivet: (2013)
• No Effect of a Single Supratherapeutic Dose of Lersivirine, a Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor, on Corrected QT Interval in Healthy Subjects
  af: Vourvahis, Manoli, et al.
  Udgivet: (2012)